Sun Pharma Advanced Research Co Ltd SPARC-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 3:29 PM IST
245.65quote price arrow up+2.30 (+0.95%)
Volume
1,171,559
52 week range
141.00 - 264.90

...

Loading . . .
  • Open245.00
  • Day High251.80
  • Day Low243.75
  • Prev Close243.35
  • 52 Week High264.90
  • 52 Week High Date06/09/21
  • 52 Week Low141.00
  • 52 Week Low Date03/31/21

Key Stats

  • Market Cap889.52M
  • Shares Out262.05M
  • 10 Day Average Volume2.72M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change24.89

KEY STATS

  • Open245.00
  • Day High251.80
  • Day Low243.75
  • Prev Close243.35
  • 52 Week High264.90
  • 52 Week High Date06/09/21
  • 52 Week Low141.00
  • 52 Week Low Date03/31/21
  • Market Cap889.52M
  • Shares Out262.05M
  • 10 Day Average Volume2.72M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change24.89

RATIOS/PROFITABILITY

  • EPS (TTM)-5.77
  • P/E (TTM)-42.57
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sun Pharma Advanced Research Co Ltd

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Sun Pharma Advanced Research Company Limited is engaged in the research and experimental development on natural sciences and engineering (Pharmacy). The Company operates through Pharmaceuticals Research & Development segment. Its programs include Xelpros, Elepsia XR, Baclofen GRS, Paclitaxel Injection Concentrate for Nanodispersion (Taclantis), Salmeterol - Fluticasone Dry Powder Inhaler (DPI), SUN-K706, Brimonidine OD, Tizanidine ER, Minocycline Topical and SUN-597 Topical....
Dilip Shanghvi
Non-Executive Chairman
Anil Raghavan
Chief Executive Officer
Chetan Rajpara
Chief Financial Officer
Address
17B Mahal Industrial Estate
Mahakali Caves Road, Andheri (East)
Mumbai
400093
India